+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Cardiac Biomarkers Testing Market (2022-2027) by Type, Product Type, Disease, Testing, Application, Geography, Competitive Analysis, and the Impact of Covid-19 with Ansoff Analysis

  • PDF Icon


  • 180 Pages
  • April 2022
  • Region: Global
  • Infogence Global Research
  • ID: 5601474
UP TO OFF until Dec 31st 2023
The Global Cardiac Biomarkers Testing Market is estimated to be USD 4.21 Bn in 2022 and is projected to reach USD 6.14 Bn by 2027, growing at a CAGR of 7.84%.

Market Dynamics

Market dynamics are forces that impact the prices and behaviors of the Global Cardiac Biomarkers Testing Market stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

Market Segmentations

The Global Cardiac Biomarkers Testing Market is segmented based on Type, Product Type, Disease, Testing, Application, and Geography.
  • By Type, the market is classified into Bnp Or Nt-Probnp (Natriuretic Peptides), CK-MB (Creatine Kinase ), HsCRP, Myoglobin, Troponin I&T, and Ischemia Modified Albumin (IMA).
  • By Product Type, the market is classified into Instruments and Reagents & Kits.
  • By Disease, the market is classified into Congestive Heart Failure and Myocardial Infarction.
  • By Testing, the market is classified into Laboratory Testing and Point-Of-Care Testing.
  • By Application, the market is classified into Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome (ACS), Atherosclerosis, and Other.
  • By Geography, the market is classified into Americas, Europe, Middle-East & Africa and Asia-Pacific.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Abbott Laboratories, Beckman Coulter, Biomérieux, Bio-Rad Laboratories, etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

  • The report presents a detailed Ansoff matrix analysis for the Global Cardiac Biomarkers Testing Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
  • The report analyses the Global Cardiac Biomarkers Testing Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
  • Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Cardiac Biomarkers Testing Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the analyst's Proprietary competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including the parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market
Frequently Asked Questions about the Global Cardiac Biomarkers Testing Market

What is the estimated value of the Global Cardiac Biomarkers Testing Market?

The Global Cardiac Biomarkers Testing Market was estimated to be valued at $4.21 Billion in 2022.

What is the growth rate of the Global Cardiac Biomarkers Testing Market?

The growth rate of the Global Cardiac Biomarkers Testing Market is 7.8%, with an estimated value of $6.14 Billion by 2027.

What is the forecasted size of the Global Cardiac Biomarkers Testing Market?

The Global Cardiac Biomarkers Testing Market is estimated to be worth $6.14 Billion by 2027.

Who are the key companies in the Global Cardiac Biomarkers Testing Market?

Key companies in the Global Cardiac Biomarkers Testing Market include Abbott Laboratories, Beckman Coulter, Biomérieux, Bio, Rad Laboratories, DiaSorin, Ortho Clinical Diagnostics, PerkinElmer, Randox laboratories and Roche Diagnostics.

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations and Outlook
4 Market Dynamics
4.1 Drivers
4.1.1 Increasing Prevalence of Cardiovascular Diseases
4.1.2 Rapidly Increasing Geriatric Population
4.1.3 Increases Demand for Non-Invasive Biomarkers
4.2 Restraints
4.2.1 Technical Difficulty Related to Sample Collection and Storage
4.3 Opportunities
4.3.1 PoInt-of-Care Testing (PoCT) with Cardiac Biomarkers
4.3.2 Personalized Medicine
4.4 Challenges
4.4.1 Loosely Defined Reimbursement Systems
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
6 Global Cardiac Biomarkers Testing Market, By Type
6.1 Introduction
6.2 Bnp Or Nt-Probnp (Natriuretic Peptides)
6.3 CK-MB (Creatine Kinase )
6.4 HsCRP
6.5 Myoglobin
6.6 Troponin I and T
6.7 Ischemia Modified Albumin (IMA)
7 Global Cardiac Biomarkers Testing Market, By Product Type
7.1 Introduction
7.2 Instruments
7.2.1 Chemiluminescence
7.2.2 ELISA
7.2.3 Immunochromatography
7.2.4 Immunofluorescence
7.3 Reagents and Kits
8 Global Cardiac Biomarkers Testing Market, By Disease
8.1 Introduction
8.2 Congestive Heart Failure
8.3 Myocardial Infarction
9 Global Cardiac Biomarkers Testing Market, By Testing
9.1 Introduction
9.2 Laboratory Testing
9.3 Point-Of-Care Testing
10 Global Cardiac Biomarkers Testing Market, By Application
10.1 Introduction
10.2 Myocardial Infarction
10.3 Congestive Heart Failure
10.4 Acute Coronary Syndrome (ACS)
10.5 Atherosclerosis
10.6 Other
11 Americas’ Cardiac Biomarkers Testing Market
11.1 Introduction
11.2 Argentina
11.3 Brazil
11.4 Canada
11.5 Chile
11.6 Colombia
11.7 Mexico
11.8 Peru
11.9 United States
11.10 Rest of Americas
12 Europe’s Cardiac Biomarkers Testing Market
12.1 Introduction
12.2 Austria
12.3 Belgium
12.4 Denmark
12.5 Finland
12.6 France
12.7 Germany
12.8 Italy
12.9 Netherlands
12.10 Norway
12.11 Poland
12.12 Russia
12.13 Spain
12.14 Sweden
12.15 Switzerland
12.16 United Kingdom
12.17 Rest of Europe
13 Middle East and Africa’s Cardiac Biomarkers Testing Market
13.1 Introduction
13.2 Egypt
13.3 Israel
13.4 Qatar
13.5 Saudi Arabia
13.6 South Africa
13.7 United Arab Emirates
13.8 Rest of MEA
14 APAC’s Cardiac Biomarkers Testing Market
14.1 Introduction
14.2 Australia
14.3 Bangladesh
14.4 China
14.5 India
14.6 Indonesia
14.7 Japan
14.8 Malaysia
14.9 Philippines
14.10 Singapore
14.11 South Korea
14.12 Sri Lanka
14.13 Thailand
14.14 Taiwan
14.15 Rest of Asia-Pacific
15 Competitive Landscape
15.1 Competitive Quadrant
15.2 Market Share Analysis
15.3 Strategic Initiatives
15.3.1 M&A and Investments
15.3.2 Partnerships and Collaborations
15.3.3 Product Developments and Improvements
16 Company Profiles
16.1 Abbott Laboratories
16.2 Beckman Coulter
16.3 Biomérieux
16.4 Bio-Rad Laboratories
16.5 DiaSorin
16.6 Ortho Clinical Diagnostics
16.7 PerkinElmer
16.8 Randox laboratories
16.9 Roche Diagnostics
16.10 Siemens Healthineers
16.11 Thermo Fisher Scientific
16.12 Tosoh
17 Appendix
17.1 Questionnaire

Companies Mentioned

  • Abbott Laboratories
  • Beckman Coulter
  • Biomérieux
  • Bio-Rad Laboratories
  • DiaSorin
  • Ortho Clinical Diagnostics
  • PerkinElmer
  • Randox laboratories
  • Roche Diagnostics
  • Siemens Healthineers
  • Thermo Fisher Scientific
  • Tosoh